Literature DB >> 727174

Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

A L Barry, C Thornsberry, R N Jones, P C Fuchs, T L Gavan, E H Gerlach.   

Abstract

Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins. Am J Clin Pathol 70: 909--913, 1978. Studies were carried out to determine whether susceptibility or resistance to 11 cephalosporins could be predicted reliably from the results of tests with a single cephalothin disk. The cephalosporins were tested with a microdilution technic and with a standardized disk test. Strains susceptible to a cephalothin disk were predictably susceptible to all other cephalosporins. However, 2--12% of the strains were resistant to cephalothin disks but were susceptible to the more active parenteral drugs cefoxitin, cephamandole, cefuroxime, and BL-S786. Because of differences in antimicrobial activities, the cephalosporins could be divided into three subgroups for purposes of susceptibility testing: one subgroup includes the majority of cephalosporins and may be represented by tests with cephalothin, the second subgroup inclues three active parenteral drugs (cephamandole, cefuroxime, and BL-S786) and may be represented by tests with cefuroxime, and the third subgroup consists of cefoxitin, a cephamycin with a unique broad spectrum of activity. Until the drugs in the second and third subgroups are released for general therapeutic use, the practice of testing only one cephalosporin disk appears to be a reasonably reliable procedure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727174     DOI: 10.1093/ajcp/70.6.909

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Biographical Feature: Clyde Thornsberry, Ph.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Comparison of cefadroxil and cephalothin disk susceptibility test results.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

3.  Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.

Authors:  J C Fung-Tomc; E Huczko; T Stickle; B Minassian; B Kolek; K Denbleyker; D Bonner; R Kessler
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

4.  Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

5.  Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.

Authors:  D A Preston; R N Jones; A L Barry; C Thornsberry
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

7.  [In vitro testing of newer cephalosporins (author's transl)].

Authors:  G Linzenmeier; E Rosenthal
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.

Authors:  D N Wright; D F Welch; B A Saxon; S J Clark; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.

Authors:  H M Miles; M Carson; E R Pavillard
Journal:  Drugs       Date:  1981       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.